Mid-Day Market Update: Nasdaq Rises 150 Points; NCR Shares Plunge
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 300 points on Wednesday.
BTIG Upgrades Acutus Medical to Buy, Announces $2 Price Target
BTIG analyst Marie Thibault upgrades Acutus Medical (NASDAQ:AFIB) from Neutral to Buy and announces $2 price target.
Acutus Medical Stock Soars On Debt Refinancing, Divestiture Of Left-Heart Access Portfolio
Acutus Medical Inc (NASDAQ:AFIB) shares are skyrocketing on a commitment letter from Deerfield Management Company to refinance its existing debt with…
Goldman Sachs Maintains Neutral on Acutus Medical, Lowers Price Target to $1
Goldman Sachs maintains Acutus Medical (NASDAQ:AFIB) with a Neutral and lowers the price target from $5 to $1.
Stocks That Hit 52-Week Lows On Friday
During Friday's morning session, 234 stocks hit new 52-week lows.
